INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
SEC FORM 4/Option exerciseVerified data

Kapadia Sandip reported HRMY

CHIEF FINANCIAL OFFICER · Harmony Biosciences Holdings, Inc. · Common Stock

Side
M
Value
—
Shares
4,725
Price
—
Executed
Jan 25, 2026
Disclosed
Jan 26, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 25 executedJan 26, 2026 disclosed

HRMY · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HRMY

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$34K
    800 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$12K
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    35
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$1.54M
    35.9K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$28K
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$12K
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    20
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$319K
    10.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    20
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$770K
    25.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    24
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$77K
    1,800 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    14
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    25.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    14
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    10.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$27K
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$43K
    1,000 sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    38
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$231K
    5,500 sh
    		Sep 4, 2026Sep 9, 2026
    traded Sep 4, 2026
    		+5dSEC FORM 4

    Evidence

    28
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$190K
    4,500 sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    23
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$374K
    12.2K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    19
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$326K
    10.8K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001677141-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 25, 2026
    Published
    Jan 26, 2026
    Ingested by INSIDER
    Nov 5, 04:20 UTC
    Last re-read
    Nov 5, 04:20 UTC

    Extracted facts

    Filer
    Kapadia Sandip
    Role
    CHIEF FINANCIAL OFFICER
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Harmony Biosciences Holdings, Inc.
    Ticker
    HRMY
    Shares
    4,725
    Price per share
    $0
    Execution date (reported)
    Jan 25, 2026
    Owned after transaction
    4,725 shares
    Days from execution to publication
    1

    What this establishes

    Kapadia Sandip filed this Form 4 reporting a option exercise of HRMY on Jan 25, 2026. It became public on Jan 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    CHIEF FINANCIAL OFFICER
    Kapadia Sandipcik:0001677141
    Issuer
    Harmony Biosciences Holdings, Inc.cik:0001802665

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.